Novo Nordisk Bets On Local Tie-Ups, Price Cuts As Generic Weight-Loss Drugs Crowd In
Novo Nordisk has tied-up with local drugmakers that have extensive distribution networks to offset some of the effects of semaglutide patent expiries.
What's Your Reaction?